Transplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousBone Marrow TransplantationTransplantation ConditioningStem Cell TransplantationLiver TransplantationHematopoietic Stem Cell MobilizationGraft SurvivalStem CellsMultiple MyelomaSurvival RateAntigens, CD34Kidney TransplantationTreatment OutcomeMelphalanPeripheral Blood Stem Cell TransplantationCombined Modality TherapyDisease-Free SurvivalHematopoiesisGraft vs Host DiseaseCell TransplantationSurvival AnalysisWhole-Body IrradiationCell SurvivalLymphoma, Non-HodgkinGranulocyte Colony-Stimulating FactorSalvage TherapyRecurrenceHeart TransplantationBone Marrow PurgingAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesHematologic NeoplasmsCyclophosphamideBone Marrow CellsLung TransplantationLeukapheresisTime FactorsRemission InductionCarmustineBone MarrowColony-Forming Units AssayBusulfanTissue DonorsCells, CulturedCell DifferentiationTransplantation ChimeraFollow-Up StudiesEtoposideImmunosuppressive AgentsOrgan TransplantationGraft RejectionCell SeparationHodgkin DiseaseMyeloablative AgonistsCytarabineFlow CytometryCord Blood Stem Cell TransplantationBlood Transfusion, AutologousMice, Inbred C57BLCell LineageTransplantation ImmunologyLeukemiaGraft vs Tumor EffectTransplantationPancreas TransplantationIslets of Langerhans TransplantationPrognosisGenetic TherapyLentivirusTransduction, GeneticTransplantation, IsogeneicGenetic VectorsLeukemia, Myeloid, AcuteStem Cell NicheMyelodysplastic SyndromesThalidomideMesenchymal Stem Cell TransplantationHistocompatibility TestingKanamycin KinaseAntigens, CDVincristineBlood Cell CountCell Culture TechniquesLymphomaAdult Stem CellsFeasibility StudiesBlood Component RemovalFetal BloodNeoplasm, ResidualCell ProliferationAntineoplastic AgentsProspective StudiesLiving DonorsAntineoplastic Agents, AlkylatingTransplantation, HeterologousNeoplastic Stem CellsImmunomagnetic Separation